Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
about
Evolutionary Pareto-optimization of stably folding peptidesLarge-scale interaction profiling of PDZ domains through proteomic peptide-phage display using human and viral phage peptidomesNatural intracellular peptides can modulate the interactions of mouse brain proteins and thimet oligopeptidase with 14-3-3ε and calmodulinPepComposer: computational design of peptides binding to a given protein surfaceComputer-based de novo designs of tripeptides as novel neuraminidase inhibitors.Display technologies: application for the discovery of drug and gene delivery agents.Genetic selection for peptide inhibitors of angiogenin.Phenotypic screening of phylomer peptide libraries derived from genome fragments to identify and validate new targets and therapeutics.In vitro methods for peptide display and their applications.Host defence peptides: antimicrobial and immunomodulatory activity and potential applications for tackling antibiotic-resistant infections.Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.The SCHOOL of nature: III. From mechanistic understanding to novel therapiesMean protein evolutionary distance: a method for comparative protein evolution and its application.Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domainKnowledge-based modeling of peptides at protein interfaces: PiPreD.NMEGylation: a novel modification to enhance the bioavailability of therapeutic peptides.Peptide structure stabilization by membrane anchoring and its general applicability to the development of potent cell-permeable inhibitors.An Amphiphilic Peptide Induces Apoptosis Through the miR29b-p53 Pathway in Cancer CellsEvidence of an Antimicrobial Peptide Signature Encrypted in HECT E3 Ubiquitin Ligases.Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry.A survey of peptides with effective therapeutic potential in Alzheimer's disease rodent models or in human clinical studies.Targeting malignant mitochondria with therapeutic peptides.Review cyclic peptides on a merry-go-round; towards drug design.Zebrafish as a model to evaluate peptide-related cancer therapies.Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.Reversal effect of rosmarinic acid on multidrug resistance in SGC7901/Adr cell.A systematic molecular dynamics approach to the study of peptide Keap1-Nrf2 protein-protein interaction inhibitors and its application to p62 peptides.Intracellular peptides as natural regulators of cell signaling.Novel neuroprotective action of prothymosin α-derived peptide against retinal and brain ischemic damages.Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide.A novel bradykinin potentiating peptide isolated from Bothrops jararacussu venom using catallytically inactive oligopeptidase EP24.15.Protein silencing with Phylomers: a new tool for target validation and generating lead biologicals targeting protein interactions.Electron capture dissociation product ion abundances at the X amino acid in RAAAA-X-AAAAK peptides correlate with amino acid polarity and radical stability.Bio-inspired design and potential biomedical applications of a novel class of high-affinity peptides.A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular deliveryApplication of plug-plug technique to ACE experiments for discovery of peptides binding to a larger target protein: A model study of calmodulin-binding fragments selected from a digested mixture of reduced BSAPeptides: minimal drug surrogates to interrogate and interfere with protein function
P2860
Q27649880-7B5F5012-01F5-4F4F-8940-1C6EE8FC292DQ28115000-5ECC1247-9C7F-4D48-9E6D-292DA4111C9CQ28573313-1D528125-F7E3-4019-9155-64DAEE3ED15EQ29048212-465F97AE-B4B6-4E8E-B081-50B16021DEE2Q30403144-7DAE19D4-E6E9-4854-A39F-D1839C1B9D98Q33264491-6C8DDC19-31C4-4A1C-8564-5677BB99E674Q33321756-0AC7F645-34B2-4229-A160-7160E49D40A0Q33852350-96F16567-F055-47DA-949F-FDD9D1F5AEE1Q33917861-381431DD-059D-4980-889F-C16270F5FF66Q34264486-534A8766-D402-4A1E-AB5E-05CD20D49E45Q34291876-33C04DB5-2F2D-4C21-AD67-E9B96A71F878Q34619705-C69F314C-EB71-46CA-8CC0-72A4643DFCEBQ34684246-0A748410-9A8C-4B5A-8D02-6AE750AAAEA9Q34989840-DBCA3B62-5826-427C-AAFA-02B12AB51C54Q35533965-3B669466-0C1E-470A-91F9-CBAA182BAAE2Q35627471-FDCDEAFA-5426-485E-BE22-2BC05EE819B6Q36384434-8E1DCF75-0126-431A-BFDF-1619AEDACF84Q37238932-C77A85D5-7EFF-4203-B515-AFF0A4F46EBEQ37572006-81C91394-1D68-468A-B039-8057A59C68E6Q37893563-7DA2BF17-570B-4862-87D3-6946D14B907DQ37981246-C30542C8-EE5B-495E-A831-A40D3054C3FCQ38040407-2C11EB12-EE1B-45CE-978A-02F4D01C8D09Q38476515-9FEAC8A9-1307-4D19-B119-ACBA127E1E6BQ38743212-F62328D8-5A91-4210-92E7-9184C82ABEFFQ39138015-63A2A36E-29B5-40BE-B941-C3E26C8DD5BEQ39192058-93B0BC0B-16DE-464A-9FBD-571B4C306834Q39953670-50848DB8-97AC-47DE-814A-601EB23395CFQ40453770-0E519A3F-A85C-43D4-8307-F5BAA8CDC4D0Q43831952-D8D4D25F-B454-4AED-A720-F197E1E48DC7Q44764096-918B8BA6-045E-4195-B0DD-5A2E159A40E8Q46654777-82BF0C3D-C6D1-4E3F-AA8C-A9270E55F30DQ50923792-6C38AB64-C4B3-4425-89F8-85AE3BE7D806Q51786744-4D287346-1728-4490-9E69-7917AE968288Q55462323-3AC47379-AE3E-4A75-BDF8-F3916F29268AQ57524985-9D2087F3-7CE6-40ED-BF1D-BB22C42AF801Q57893613-7A928657-0EA6-4938-937E-D44ABC0944E8Q58046173-3D6A8FD3-CA71-422D-9482-0A611CA5B0BE
P2860
Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
@ast
Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
@en
type
label
Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
@ast
Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
@en
prefLabel
Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
@ast
Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
@en
P2860
P356
P1433
P1476
Screening for peptide drugs from the natural repertoire of biodiverse protein folds.
@en
P2093
Paul M Watt
P2860
P2888
P304
P356
10.1038/NBT1190
P577
2006-02-01T00:00:00Z
P5875
P6179
1032544270